It is important to note that the details provided here are for educational purposes only and are not intended as a recommendation for human consumption
Indeed, GLP-1RA therapy appears to be well tolerated overall, and proportions of clinical trial participants discontinuing treatment because of adverse events tend to be low (5.49.9%) [10, 37, 39, 43, 46, 47]
Bajaj, M.D., from LMC Diabetes and Endocrinology in Brampton, Ontario, Canada, and colleagues examined the efficacy and safety of retatrutide as a monotherapy in a 40-week phase 3 trial involving adults with type 2 diabetes inadequately controlled by diet and exercise alone
The medication is available without insurance in all 50 states and is HSA/FSA eligible, making it accessible regardless of coverage status
Nutritional Shifts Redefine Grocery Sales Nearly every GLP-1 user surveyed95%reported making healthier food choices